125,000 Shares in Teladoc Health, Inc. (NYSE:TDOC) Purchased by Monaco Asset Management SAM

Monaco Asset Management SAM bought a new stake in shares of Teladoc Health, Inc. (NYSE:TDOC) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 125,000 shares of the health services provider’s stock, valued at approximately $1,222,000.

Other large investors also recently added to or reduced their stakes in the company. Quest Partners LLC raised its position in shares of Teladoc Health by 332.7% during the second quarter. Quest Partners LLC now owns 65,763 shares of the health services provider’s stock valued at $643,000 after buying an additional 50,565 shares during the last quarter. Acadian Asset Management LLC increased its holdings in Teladoc Health by 391.4% in the 2nd quarter. Acadian Asset Management LLC now owns 32,607 shares of the health services provider’s stock valued at $318,000 after acquiring an additional 25,971 shares during the last quarter. Arizona State Retirement System lifted its stake in Teladoc Health by 4.2% in the 2nd quarter. Arizona State Retirement System now owns 47,400 shares of the health services provider’s stock worth $464,000 after purchasing an additional 1,901 shares in the last quarter. Foundations Investment Advisors LLC lifted its stake in Teladoc Health by 101.2% in the 2nd quarter. Foundations Investment Advisors LLC now owns 58,934 shares of the health services provider’s stock worth $576,000 after purchasing an additional 29,646 shares in the last quarter. Finally, Rhumbline Advisers boosted its holdings in shares of Teladoc Health by 62.9% during the 2nd quarter. Rhumbline Advisers now owns 276,535 shares of the health services provider’s stock valued at $2,704,000 after purchasing an additional 106,770 shares during the last quarter. 76.82% of the stock is owned by hedge funds and other institutional investors.

Teladoc Health Stock Down 4.1 %

Shares of NYSE TDOC opened at $7.20 on Tuesday. The company has a market cap of $1.22 billion, a P/E ratio of -5.11 and a beta of 0.90. The firm has a 50-day simple moving average of $8.21 and a two-hundred day simple moving average of $11.28. Teladoc Health, Inc. has a 1 year low of $6.76 and a 1 year high of $22.98. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.66 and a quick ratio of 1.62.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, July 31st. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.36) by $0.08. The firm had revenue of $642.44 million during the quarter, compared to analyst estimates of $649.34 million. Teladoc Health had a negative return on equity of 10.25% and a negative net margin of 38.54%. Research analysts anticipate that Teladoc Health, Inc. will post -0.73 earnings per share for the current year.

Insider Transactions at Teladoc Health

In other Teladoc Health news, COO Michael Willem Waters sold 4,218 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total value of $30,200.88. Following the completion of the sale, the chief operating officer now directly owns 78,309 shares of the company’s stock, valued at approximately $560,692.44. The transaction was disclosed in a filing with the SEC, which is available through this link. In other Teladoc Health news, insider Vidya Raman-Tangella sold 3,857 shares of the company’s stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total value of $31,395.98. Following the completion of the sale, the insider now directly owns 33,667 shares in the company, valued at approximately $274,049.38. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, COO Michael Willem Waters sold 4,218 shares of the firm’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total value of $30,200.88. Following the transaction, the chief operating officer now owns 78,309 shares in the company, valued at approximately $560,692.44. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 57,819 shares of company stock worth $442,204. 0.95% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several brokerages have recently issued reports on TDOC. Bank of America reduced their target price on Teladoc Health from $16.50 to $13.50 and set a “neutral” rating on the stock in a report on Tuesday, May 14th. Evercore ISI decreased their price objective on Teladoc Health from $14.00 to $10.00 and set an “in-line” rating on the stock in a report on Tuesday, July 9th. Piper Sandler cut their target price on shares of Teladoc Health from $25.00 to $10.00 and set an “overweight” rating for the company in a report on Tuesday, August 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of Teladoc Health in a research note on Thursday, August 1st. Finally, Barclays lowered their price objective on shares of Teladoc Health from $20.00 to $10.00 and set an “overweight” rating for the company in a research report on Thursday, August 1st. Fourteen equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $12.44.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.